Literature DB >> 29079698

Transgenic Mice Expressing Human Proteinase 3 Exhibit Sustained Neutrophil-Associated Peritonitis.

Katherine R Martin1,2,3,4, Magali Pederzoli-Ribeil1,2,3,4, Emeline Pacreau4,5,6, Sabrina S Burgener7,8,9, Albert Dahdah4,5,6, Céline Candalh1,2,3,4, Evelyne Lauret1,2,3, Marc Foretz1,2,3, Luc Mouthon1,2,3,4,10, Bruno Lucas1,2,3, Nathalie Thieblemont1,2,3,4, Charaf Benarafa7,8, Pierre Launay4,5,6, Véronique Witko-Sarsat11,2,3,4.   

Abstract

Proteinase 3 (PR3) is a myeloid serine protease expressed in neutrophils, monocytes, and macrophages. PR3 has a number of well-characterized proinflammatory functions, including cleaving and activating chemokines and controlling cell survival and proliferation. When presented on the surface of apoptotic neutrophils, PR3 can disrupt the normal anti-inflammatory reprogramming of macrophages following the phagocytosis of apoptotic cells. To better understand the function of PR3 in vivo, we generated a human PR3 transgenic mouse (hPR3Tg). During zymosan-induced peritonitis, hPR3Tg displayed an increased accumulation of neutrophils within the peritoneal cavity compared with wild-type control mice, with no difference in the recruitment of macrophages or B or T lymphocytes. Mice were also subjected to cecum ligation and puncture, a model used to induce peritoneal inflammation through infection. hPR3Tg displayed decreased survival rates in acute sepsis, associated with increased neutrophil extravasation. The decreased survival and increased neutrophil accumulation were associated with the cleavage of annexin A1, a powerful anti-inflammatory protein known to facilitate the resolution of inflammation. Additionally, neutrophils from hPR3Tg displayed enhanced survival during apoptosis compared with controls, and this may also contribute to the increased accumulation observed during the later stages of inflammation. Taken together, our data suggest that human PR3 plays a proinflammatory role during acute inflammatory responses by affecting neutrophil accumulation, survival, and the resolution of inflammation.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29079698     DOI: 10.4049/jimmunol.1601522

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

Review 1.  Expanding Neutrophil Horizons: New Concepts in Inflammation.

Authors:  Simon M Chatfield; Nathalie Thieblemont; Véronique Witko-Sarsat
Journal:  J Innate Immun       Date:  2018-09-26       Impact factor: 7.349

Review 2.  Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.

Authors:  Peter Lamprecht; Anja Kerstein; Sebastian Klapa; Susanne Schinke; Christian M Karsten; Xinhua Yu; Marc Ehlers; Jörg T Epplen; Konstanze Holl-Ulrich; Thorsten Wiech; Kathrin Kalies; Tanja Lange; Martin Laudien; Tamas Laskay; Timo Gemoll; Udo Schumacher; Sebastian Ullrich; Hauke Busch; Saleh Ibrahim; Nicole Fischer; Katrin Hasselbacher; Ralph Pries; Frank Petersen; Gesche Weppner; Rudolf Manz; Jens Y Humrich; Relana Nieberding; Gabriela Riemekasten; Antje Müller
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

3.  Identifying important parameters in the inflammatory process with a mathematical model of immune cell influx and macrophage polarization.

Authors:  Marcella Torres; Jing Wang; Paul J Yannie; Shobha Ghosh; Rebecca A Segal; Angela M Reynolds
Journal:  PLoS Comput Biol       Date:  2019-07-31       Impact factor: 4.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.